The Involvement of Natural Killer Cells in the Pathogenesis of Severe Acute Respiratory Syndrome

American Journal of Clinical Pathology

Volumn 121, Issue 4, 2004, Pages 507-511

  Wang, Chen ^a   Xia, Cheng Qing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Immunoglobulin like receptor; Mycoplasma pneumoniae; NK cell; Severe acute respiratory syndrome

Indexed keywords

ANTIGEN; CD158B ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SARS CORONAVIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 1642281695     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/WPK7Y2XKNF4CBF3R     Document Type: Article

References (16)

1. Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967-1976.
2. Ksiazek TG, Erdman D, Goldsmith C, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1995-2005.
3. National Research Project for SARS, Beijing Group. Dynamic changes of T-lymphocytes and immunoglobulins in patients with severe acute respiratory syndrome. Zhong Hua Yi Xue Za Zhi. 2003;83:1014-1017.
4. Yin C, Zhang F, Tang X, et al. Measurement of subsets of blood T lymphocyte in 93 patients with severe acute respiratory syndrome. Chin J Tuberc Respir Dis. 2003;26:343-346.
5. Norris S, Doherty DG, Curry M, et al. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Cancer Immunol Immunother. 2003;52:53-58.
6. Dukers DF, Vermeer MH, Jaspars LH, et al. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype. J Clin Pathol. 2001;54:224-228.
7. Ahmad R, Sindhu ST, Tran P, et al. Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients. J Med Virol. 2001;65:431-440.
8. Husain Z, Levitan E, Mirza NM, et al. HLA-Cw7 zygosity affects the size of subset of CD158b+ natural killer cells. J Clin Immunol. 2002;22:28-36.
9. Kogure T, Mantani N, Goto H, et al. The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human. Mediators Inflamm. 2002;11:219-224.
10. Imamura M, Tsutsumi Y, Miura Y, et al. Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation. Hematology. 2003;8:19-26.
11. Becker S, Tonn T, Fussel T, et al. Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. Hum Immunol. 2003;64:183-193.
12. Hu PF, Hultin LE, Hultin P, et al. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16 dim CD56-cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:331-340.
13. Sepulveda C, Puente J, Weinstein C, et al. Enhancement of natural killer cell activity in HIV-1-infected subjects by a mixture of the calcium ionophore A 23187 and the phorbol ester TPA: lack of response to a similar challenge with interleukin-2 or alpha-interferon. Am J Ther. 1997;4:413-421.
14. Beijing Public Health Bureau, Haoyisheng Medical Education Center. Handbook of SARS Training. Beijing, People's Republic of China: Beijing Science and Technique Press; 2003:14-16.
15. Black PL, McKinnon KM, Wooden SL, et al. Antiviral activity of biological response modifiers in a murine model of AIDS: requirement for augmentation of natural killer cell activity and synergy with oral AZT. Int J Immunopharmacol. 1996;18:633-650.
16. Nair MP, Schwartz SA. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I. Cell Mol Biol (Noisy-le-grand). 1997;43:969-979.